9 Results for "

MMP-13-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "MMP-13-IN-1" in MCE Product Catalog:

Cat. No.: HY-154868
CAS No.: 2925249-49-4
Target:  

MMP

Research Areas:  

Cardiovascular Disease Cancer

MMP-13-IN-1 is a potent and selective inhibitor of MMP-13 with a IC50 value of 16 nM. MMP-13-in-1 can be used for atherosclerosis research .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-N1463
CAS No.: 29741-10-4
Synonyms: LuteolIN 7-glucuronide
Luteolin 7-O-glucuronide could inhibit Matrix Metalloproteinases (MMP) activities, with IC50s of 17.63, 7.99, 11.42, 12.85, 0.03 μM for MMP-1, MMP-3, MMP-8, MMP-9, MMP-13, respectively .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W011085
CAS No.: 210755-45-6
Target:  

MMP

Research Areas:  

Inflammation/Immunology

CP-471474 is an orally active and pan MMP inhibitor, with IC50 values of 1170 nM (MMP-1), 0.7 nM (MMP-2), 16 nM (MMP-3), 13 nM (MMP-9) and 0.9 nM (MMP-13), respectively .
loading...
    loading...
Cat. No.: HY-117970
CAS No.: 1382722-47-5
Purity:  99.87%
Target:  

MMP

Research Areas:  

Cardiovascular Disease

MMPI-1154 is a promising novel cardio-cytoprotective imidazole-carboxylic acid (ICA) MMP-2 inhibitor(IC50=6.6 μM) and can be used for the study of acute myocardial infarction. MMPI-1154 also inhibits the activity of MMP-13, MMP-1 and MMP-9 with IC50s of 1.8 μM,10 μM, and 13 μM, respectively .
loading...
    loading...
Cat. No.: HY-112160
CAS No.: 1356992-21-6
Target:  

MMP

Research Areas:  

Cardiovascular Disease

XL-784 free base is a selective matrix metalloproteinases (MMP) inhibitor, with IC50s of ~1900, 0.81, 120, 10.8, 18, 0.56 nM for MMP-1, MMP-2, MMP-3, MMP-8, MMP-9 and MMP-13, respectively .
loading...
    loading...
Cat. No.: HY-N1463R
CAS No.: 29741-10-4
Synonyms: LuteolIN 7-glucuronide (Standard)
Luteolin 7-O-glucuronide (Standard) is the analytical standard of Luteolin 7-O-glucuronide. This product is intended for research and analytical applications. Luteolin 7-O-glucuronide could inhibit Matrix Metalloproteinases (MMP) activities, with IC50s of 17.63, 7.99, 11.42, 12.85, 0.03 μM for MMP-1, MMP-3, MMP-8, MMP-9, MMP-13, respectively .
loading...
    loading...
Cat. No.: HY-114396
CAS No.: 960113-85-3
Target:  

MMP

Research Areas:  

Cancer

BR351 is a brain penetrant MMP inhibitor with IC50s of 4, 2, 11, 50 nM for MMP2, MMP8, MMP9 and MMP13, respectively .
loading...
    loading...
Cat. No.: HY-43586
CAS No.: 960113-89-7
Target:  

MMP

Research Areas:  

Cancer

BR351 precursor is a precursor of BR351. BR351 is a brain penetrant MMP inhibitor with IC50s of 4, 2, 11, 50 nM for MMP2, MMP8, MMP9 and MMP13, respectively .
loading...
    loading...
Cat. No.: HY-119138
CAS No.: 321344-32-5
Target:  

p38 MAPK MMP PGE synthase

Research Areas:  

Inflammation/Immunology

R-130823 is an orally active, highly selective p38α inhibitor with an IC50 of 22 nM against p38α, an IC50 of 820 nM against p38β, and no activity against p38γ or p38δ. R-130823 downregulates downstream cartilage degradation and inflammatory mediators, and inhibits the release of MMP-13, MMP-1 and PGE2. R-130823 reduces hind paw swelling, improves hyperalgesia, and blocks arthritis progression. R-130823 is applicable to research related to osteoarthritis and rheumatoid arthritis .
loading...
    loading...